Related Experiment Video
Updated: Apr 21, 2026
Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery
Published on: June 7, 2024
Repurposing tumor-derived extracellular vesicles with an adhesive carboxymethyl chitosan-based hydrogel for spinal
Kuan-Lin Wang1, Yu-Che Hsiao2, Wen-Yu Pan3
1Research Center for Applied Sciences, Academia Sinica, Taipei, 115201, Taiwan; Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 300044, Taiwan.
Abstract:
Spinal cord injury (SCI) triggers a cascade of pathological events, including persistent neuroinflammation and glial scar formation, which severely hinder axonal regeneration and motor functional recovery. Inspired by the immunosuppressive and regenerative features of the tumor microenvironment, this study introduces a high-reward strategy that repurposes tumor-derived extracellular vesicles (TDEVs) for SCI repair. To ensure localized delivery and enhance safety, TDEVs are incorporated into an injectable adhesive hydrogel composed of carboxymethyl chitosan (CMC) and polydopamine (PDA), crosslinked through Schiff-base chemistry. The resulting TDEVs@CMC-PDA hydrogel adheres firmly to the injured spinal cord and enables sustained release of TDEVs, allowing targeted modulation of the injury microenvironment. In a mouse SCI model, TDEVs@CMC-PDA effectively attenuates neuroinflammation, suppresses glial scar formation, and promotes axonal regrowth and remyelination, ultimately improving motor function. Importantly, biosafety assessments reveal no evidence of systemic toxicity or transcriptional activation of oncogenic pathways. These findings highlight the therapeutic promise and safety of repurposing TDEVs with the adhesive CMC-PDA hydrogel, positioning this strategy as a compelling platform for neural regeneration and beyond.
Insights
Tumor-derived extracellular vesicles (TDEVs) delivered via an adhesive hydrogel promote spinal cord repair. This novel approach reduces neuroinflammation and glial scarring, enhancing motor function recovery and axonal regeneration.
Area of Science:
- Biomaterials Science
- Neuroscience
- Regenerative Medicine
Background:
- Spinal cord injury (SCI) causes neuroinflammation and glial scarring, impeding nerve regeneration and motor function.
- The tumor microenvironment exhibits immunosuppressive and regenerative properties that can be harnessed for therapeutic benefit.
Purpose of the Study:
- To develop a localized delivery system for tumor-derived extracellular vesicles (TDEVs) for spinal cord injury (SCI) repair.
- To evaluate the efficacy and safety of TDEVs encapsulated in an adhesive hydrogel for promoting neural regeneration.
Main Methods:
- TDEVs were incorporated into an injectable, adhesive hydrogel (carboxymethyl chitosan-polydopamine, CMC-PDA) crosslinked via Schiff-base chemistry.
- The TDEVs@CMC-PDA hydrogel was applied to a mouse SCI model for localized delivery and sustained release.
- Neuroinflammation, glial scar formation, axonal regeneration, remyelination, and motor function recovery were assessed.
Main Results:
- The TDEVs@CMC-PDA hydrogel demonstrated firm adhesion to the injured spinal cord and sustained TDEV release.
- Treatment significantly attenuated neuroinflammation and suppressed glial scar formation.
- Promoted axonal regrowth and remyelination, leading to improved motor functional recovery in the SCI model.
Conclusions:
- Repurposing TDEVs within an adhesive CMC-PDA hydrogel offers a promising strategy for SCI repair.
- This approach effectively modulates the injury microenvironment, promoting neural regeneration and functional recovery with demonstrated biosafety.
